Keith D. Salazar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Keith D. Salazar has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
John B. Barnett
Department of Microbiology, Immunology, and Cell Biology , Robert C. Byrd Health Sciences Center, West Virginia University , Morgantown, West Virginia, USA
3 shared publications- Rosana Schafer
West Virginia University School of Medicine
3 shared publications - Arnold R. Brody
Department of Pathology, Tulane University Medical School, New Orleans, LA, United States
2 shared publications Carey B. Copeland
2 shared publicationsRobert W. Luebke
2 shared publicationsSusan M. Lankford
Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina
2 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (9)
Human in vitro airway models to assess point-of-contact respiratory toxicity of surfactants and derive human equivalent concentrations after single dose exposure
Surfactants are widely used in products such as soaps, adhesives, and agrochemical formulations where they function as emulsifiers, wetting agents, detergents, foaming agents, or dispersants. Despite the potential for inhalation exposure, human-relevant hazard data are limited. Surfactants can interact with amphiphilic cell membranes, compromising membrane integrity and leading to cytotoxicity. To assess point-of-contact respiratory tissue irritation potential of these chemicals, a human bronchial epithelial cell line (BEAS-2B) and a reconstructed human respiratory epithelial (RHRE; MucilAir) model were exposed to two surfactants—oleoyl sarcosine or Triton X-100 as aerosols (BEAS-2B cells only) or liquids (in both systems). Aerosol exposures were not further pursued due to similar trends in results as liquid exposures and the need for further technical optimization. Cells were exposed for 24 h to 30 µl (91 µl/cm²) of either surfactant at five concentrations. Cellular effects were assessed after 24 h of exposure in BEAS-2B cells and MucilAir, and at 7 d after the start of exposure in MucilAir only. Generally, dose-dependent effects were observed for both surfactants within each cell system. Oleoyl sarcosine was more toxic in BEAS-2B cells compared with Triton X-100, and no clear difference in toxicity between the two surfactants was observed in MucilAir. Benchmark Dose (BMD) and multiple-path particle dosimetry (MPPD) modeling were performed to translate in vitro data to human equivalent concentrations (HECs). This manuscript demonstrates the application of an in vitro test method and in vitro to in vivo extrapolation (IVIVE) to predict point-of-contact respiratory tissue irritation in humans.
- 2 September 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (9)
Open AccessHuman in vitro airway models to assess point-of-contact respiratory toxicity of surfactants and derive human equivalent concentrations after single dose exposure
Surfactants are widely used in products such as soaps, adhesives, and agrochemical formulations where they function as emulsifiers, wetting agents, detergents, foaming agents, or dispersants. Despite the potential for inhalation exposure, human-relevant hazard data are limited. Surfactants can interact with amphiphilic cell membranes, compromising membrane integrity and leading to cytotoxicity. To assess point-of-contact respiratory tissue irritation potential of these chemicals, a human bronchial epithelial cell line (BEAS-2B) and a reconstructed human respiratory epithelial (RHRE; MucilAir) model were exposed to two surfactants—oleoyl sarcosine or Triton X-100 as aerosols (BEAS-2B cells only) or liquids (in both systems). Aerosol exposures were not further pursued due to similar trends in results as liquid exposures and the need for further technical optimization. Cells were exposed for 24 h to 30 µl (91 µl/cm²) of either surfactant at five concentrations. Cellular effects were assessed after 24 h of exposure in BEAS-2B cells and MucilAir, and at 7 d after the start of exposure in MucilAir only. Generally, dose-dependent effects were observed for both surfactants within each cell system. Oleoyl sarcosine was more toxic in BEAS-2B cells compared with Triton X-100, and no clear difference in toxicity between the two surfactants was observed in MucilAir. Benchmark Dose (BMD) and multiple-path particle dosimetry (MPPD) modeling were performed to translate in vitro data to human equivalent concentrations (HECs). This manuscript demonstrates the application of an in vitro test method and in vitro to in vivo extrapolation (IVIVE) to predict point-of-contact respiratory tissue irritation in humans.
- 1 November 2015
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 288 (3) , 439-452
Development and application of a rat PBPK model to elucidate kidney and liver effects induced by ETBE and tert-butanol
- 1 November 2015
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 288 (3) , 439-452
Development and application of a rat PBPK model to elucidate kidney and liver effects induced by ETBE and tert-butanol
- 21 December 2012
- Published by Taylor & Francis in Journal of Immunotoxicology
- Vol. 10 (4) , 329-333
Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos
The prevalence of anti-nuclear antibodies (ANA) and self-reported systemic autoimmune diseases were increased in residents of Libby, MT, as was the incidence of ANA in Lewis rats exposed to Libby amphibole (LA) asbestos. However, rats induced to develop rheumatoid arthritis (RA) did not develop autoantibodies associated with RA, nor was RA exacerbated by LA exposure, suggesting that increased ANA expression might be related to some other autoimmune process. Libby residents self-reported increased numbers of physician-diagnosed cases of systemic lupus erythematosus (SLE). Thus, the goal of this study was to determine if the increased incidence of ANA in Lewis rats exposed to LA is related to the development of SLE-like disease. Female Lewis rats were intratracheally instilled bi-weekly for 13 weeks with total doses of 0.15, 0.5, 1.5, or 5.0 mg of LA or 0.5 or 1.5 mg of a positive control fiber, amosite. ANA incidence was significantly increased in all asbestos dose groups, although no dose response was observed. The occurrence of proteinuria was increased in LA 0.5, LA 5.0, and amosite 0.5 dose groups; however, the microscopic appearance of the kidneys was normal, no binding of autoimmune complexes to glomerular surfaces was observed, and antibodies to double-stranded DNA were not elevated. Therefore, an increased prevalence of ANA in rats exposed to asbestos does not appear to correlate with disease markers typically observed in SLE. Analysis of ANA specificity for extractable nuclear antigens (ENA) determined that 98% of ENA+ samples were specific for the Jo-1 antigen. Autoantibodies to Jo-1 have been reported in patients with interstitial lung disease, suggesting that autoantibodies to Jo-1 may be a biomarker for asbestos-related pulmonary disease.
- 21 December 2012
- Published by Taylor & Francis in Journal of Immunotoxicology
- Vol. 10 (4) , 329-333
Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos
The prevalence of anti-nuclear antibodies (ANA) and self-reported systemic autoimmune diseases were increased in residents of Libby, MT, as was the incidence of ANA in Lewis rats exposed to Libby amphibole (LA) asbestos. However, rats induced to develop rheumatoid arthritis (RA) did not develop autoantibodies associated with RA, nor was RA exacerbated by LA exposure, suggesting that increased ANA expression might be related to some other autoimmune process. Libby residents self-reported increased numbers of physician-diagnosed cases of systemic lupus erythematosus (SLE). Thus, the goal of this study was to determine if the increased incidence of ANA in Lewis rats exposed to LA is related to the development of SLE-like disease. Female Lewis rats were intratracheally instilled bi-weekly for 13 weeks with total doses of 0.15, 0.5, 1.5, or 5.0 mg of LA or 0.5 or 1.5 mg of a positive control fiber, amosite. ANA incidence was significantly increased in all asbestos dose groups, although no dose response was observed. The occurrence of proteinuria was increased in LA 0.5, LA 5.0, and amosite 0.5 dose groups; however, the microscopic appearance of the kidneys was normal, no binding of autoimmune complexes to glomerular surfaces was observed, and antibodies to double-stranded DNA were not elevated. Therefore, an increased prevalence of ANA in rats exposed to asbestos does not appear to correlate with disease markers typically observed in SLE. Analysis of ANA specificity for extractable nuclear antigens (ENA) determined that 98% of ENA+ samples were specific for the Jo-1 antigen. Autoantibodies to Jo-1 have been reported in patients with interstitial lung disease, suggesting that autoantibodies to Jo-1 may be a biomarker for asbestos-related pulmonary disease.
- 21 April 2012
- Published by Springer Nature
- p. 3-30
Introduction to Immunotoxicity
- 30 March 2012
- Published by Wiley
- p. 171-192
Immunomodulation by Persistent Organic Pollutants
- 15 March 2012
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 75 (6) , 351-365
Effects of Libby Amphibole Asbestos Exposure on Two Models of Arthritis in The Lewis Rat
Epidemiological data suggest that occupational exposure to the amphibole-containing vermiculite in Libby, MT, was associated with increased risk for developing autoimmune diseases and had an odds ratio of 3.23 for developing rheumatoid arthritis (RA). The collagen-induced arthritis (CIA) and the peptidoglycan-polysaccharide (PG-PS) models of RA were employed to determine whether exposure to Libby amphibole (LA) induced a more rapid onset, increased expression, or prolonged course of RA. Female Lewis rats were intratracheally instilled with total doses of 0.15, 0.5, 1.5, or 5 mg LA or 0.5 or 1.5 mg amosite asbestos, and arthritis was induced with either the PG-PS or CIA model. Neither LA nor amosite exposure affected the disease course in the CIA model, or the production of rheumatoid factor (RF) or anti-cyclic citrullinated peptide (CCP) antibodies. LA exposure reduced swelling in the PG-PS model and decreased anti-PG-PS and total immunoglobulin M (IgM) antibody titers. Both amosite and LA exposure increased the number of rats with circulating anti-nuclear antibodies (ANA), the majority of which presented a speckled staining pattern. However, this ANA enhancement was not dose responsive. These results failed to show a positive correlation between LA exposure and RA disease in two animal models, although upregulated ANA suggest an altered immunological profile consistent with other systemic autoimmune diseases.
- 15 March 2012
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 75 (6) , 351-365
Effects of Libby Amphibole Asbestos Exposure on Two Models of Arthritis in The Lewis Rat
Epidemiological data suggest that occupational exposure to the amphibole-containing vermiculite in Libby, MT, was associated with increased risk for developing autoimmune diseases and had an odds ratio of 3.23 for developing rheumatoid arthritis (RA). The collagen-induced arthritis (CIA) and the peptidoglycan-polysaccharide (PG-PS) models of RA were employed to determine whether exposure to Libby amphibole (LA) induced a more rapid onset, increased expression, or prolonged course of RA. Female Lewis rats were intratracheally instilled with total doses of 0.15, 0.5, 1.5, or 5 mg LA or 0.5 or 1.5 mg amosite asbestos, and arthritis was induced with either the PG-PS or CIA model. Neither LA nor amosite exposure affected the disease course in the CIA model, or the production of rheumatoid factor (RF) or anti-cyclic citrullinated peptide (CCP) antibodies. LA exposure reduced swelling in the PG-PS model and decreased anti-PG-PS and total immunoglobulin M (IgM) antibody titers. Both amosite and LA exposure increased the number of rats with circulating anti-nuclear antibodies (ANA), the majority of which presented a speckled staining pattern. However, this ANA enhancement was not dose responsive. These results failed to show a positive correlation between LA exposure and RA disease in two animal models, although upregulated ANA suggest an altered immunological profile consistent with other systemic autoimmune diseases.
- Open Access
- 1 May 2010
- Published by Oxford University Press (OUP) in Proceedings of the American Thoracic Society
- Vol. 7 (2) , 130-133
Mesenchymal Stem Cells Modulate Lung Injury
Mesenchymal stem cells (MSCs) have been shown to differentiate into a variety of mesenchymal cell types, including fibroblasts, myofibroblasts, osteoblasts, chondroblasts, adipocytes, and myoblasts, as well as epithelial cells. It has been shown that these cells can be recovered from bone marrow as well as umbilical cord blood, and they can be propagated, stored, and administered to animals and patients in clinical trials. It is clear that the cells engraft in the lung, and several laboratories have demonstrated an ameliorating effect in models of acute injury caused by LPS and in chronic lung injury induced by bleomycin and asbestos. However, it is not at all clear under what conditions these cells must be applied to provide an advantage and when using these cells might cause exacerbation of the lung injury. This brief review focuses on the biology of MSCs in vitro, how the cells have been used in some animal models, and the potential for their use in therapeutic strategies for diseases as diverse as lung cancer and interstitial fibrosis.
- 1 May 2010
- Published by Oxford University Press (OUP) in Proceedings of the American Thoracic Society
- Vol. 7 (2) , 130-133
Open AccessMesenchymal Stem Cells Modulate Lung Injury
Mesenchymal stem cells (MSCs) have been shown to differentiate into a variety of mesenchymal cell types, including fibroblasts, myofibroblasts, osteoblasts, chondroblasts, adipocytes, and myoblasts, as well as epithelial cells. It has been shown that these cells can be recovered from bone marrow as well as umbilical cord blood, and they can be propagated, stored, and administered to animals and patients in clinical trials. It is clear that the cells engraft in the lung, and several laboratories have demonstrated an ameliorating effect in models of acute injury caused by LPS and in chronic lung injury induced by bleomycin and asbestos. However, it is not at all clear under what conditions these cells must be applied to provide an advantage and when using these cells might cause exacerbation of the lung injury. This brief review focuses on the biology of MSCs in vitro, how the cells have been used in some animal models, and the potential for their use in therapeutic strategies for diseases as diverse as lung cancer and interstitial fibrosis.
- 1 November 2009
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 297 (5) , L1002-L1011
Mesenchymal stem cells produce Wnt isoforms and TGF-β1 that mediate proliferation and procollagen expression by lung fibroblasts
Studies have been carried out previously to determine whether mesenchymal stem cells (MSC) influence the progression of pulmonary fibrosis. Here, we asked whether MSC (derived from mouse bone marrow and human umbilical cord blood) produce factors that mediate lung fibroblast (LF) growth and matrix production. MSC-conditioned media (CM) were found by ELISA to contain significant amounts of PDGF-AA and transforming growth factor-β1 (TGF-β1). Proliferation was increased in a concentration-dependent manner in LF cell lines and primary cells cultured in MSC-CM, but neither anti-PDGF antibodies nor PDGF receptor-specific antibodies affected proliferation, nor did a number of other antibodies to well-known mitogenic factors. However, proliferation was significantly inhibited by the Wnt signaling antagonist, secreted frizzled related protein-1 (sFRP-1). In addition, anti-Wnt1 and anti-Wnt2 antibodies attenuated MSC-CM-induced proliferation, and increased expression of Wnt7b was identified. As would be expected in cells activated by Wnt, nuclear β-catenin was increased. The amount of TGF-β1 in MSC-CM and its biological activity were revealed by activation at acidic pH. The stem cells synthesized and released TGF-β1 that increased α1-procollagen gene expression by LF target cells. Addition of anti-TGF-β to the MSC-CM blocked upregulation of collagen gene expression. These data demonstrate that MSC from mice and humans produce Wnt proteins and TGF-β1 that respectively stimulate LF proliferation and matrix production, two hallmarks of fibroproliferative lung disease. It will be essential to determine whether these factors can play a role in attempts to use MSC for therapeutic approaches.
- 1 November 2009
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 297 (5) , L1002-L1011
Mesenchymal stem cells produce Wnt isoforms and TGF-β1 that mediate proliferation and procollagen expression by lung fibroblasts
Studies have been carried out previously to determine whether mesenchymal stem cells (MSC) influence the progression of pulmonary fibrosis. Here, we asked whether MSC (derived from mouse bone marrow and human umbilical cord blood) produce factors that mediate lung fibroblast (LF) growth and matrix production. MSC-conditioned media (CM) were found by ELISA to contain significant amounts of PDGF-AA and transforming growth factor-β1 (TGF-β1). Proliferation was increased in a concentration-dependent manner in LF cell lines and primary cells cultured in MSC-CM, but neither anti-PDGF antibodies nor PDGF receptor-specific antibodies affected proliferation, nor did a number of other antibodies to well-known mitogenic factors. However, proliferation was significantly inhibited by the Wnt signaling antagonist, secreted frizzled related protein-1 (sFRP-1). In addition, anti-Wnt1 and anti-Wnt2 antibodies attenuated MSC-CM-induced proliferation, and increased expression of Wnt7b was identified. As would be expected in cells activated by Wnt, nuclear β-catenin was increased. The amount of TGF-β1 in MSC-CM and its biological activity were revealed by activation at acidic pH. The stem cells synthesized and released TGF-β1 that increased α1-procollagen gene expression by LF target cells. Addition of anti-TGF-β to the MSC-CM blocked upregulation of collagen gene expression. These data demonstrate that MSC from mice and humans produce Wnt proteins and TGF-β1 that respectively stimulate LF proliferation and matrix production, two hallmarks of fibroproliferative lung disease. It will be essential to determine whether these factors can play a role in attempts to use MSC for therapeutic approaches.
- 26 September 2008
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part B
- Vol. 11 (8) , 630-645
A Review of the Immunotoxicity of the Pesticide 3,4-Dichloropropionanalide
The pesticide 3,4-dichloropropionanilide (propanil or, alternatively, DCPA) is a member of the acetanilide chemical family and is predominantly used for the control of weeds on commercial rice crops worldwide. This article was written to provide a brief review of the general toxicity of propanil followed by a detailed summary of the immunotoxicity studies that were performed to date in mammalian in vivo and in vitro models. Propanil affects the immune system at organ, cellular, and molecular levels. Studies demonstrated that it produces thymic atrophy and splenomegaly and decreases developing T- and B-cell populations in the thymus and bone marrow. Natural killer (NK) cells and macrophages are critical components of the innate immune system. NK cell cytotoxicity and the ability of macrophages to phagocytose, kill pathogenic bacteria, and produce inflammatory cytokines are suppressed by propanil. Propanil also affects the respiratory burst of macrophages, inhibiting reactive oxygen and nitrogen species production. Molecular mechanisms responsible for propanil's effects have begun to be elucidated and include alterations in nuclear factor (NF)-κB transcription factor activity and intracellular Ca2+ signaling. Propanil exposure alters a number of functions of mature T lymphocytes and B lymphocytes that impacts the adaptive immune response. T-cell cytotoxic activity and cytokine production are major T-cell functions inhibited by propanil. The humoral antibody response to model antigens and intact bacteria is differentially affected after propanil exposure. How these changes in innate and adaptive immune responses impact the host response to bacterial challenge or vaccination has begun to be examined.
- 26 September 2008
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part B
- Vol. 11 (8) , 630-645
A Review of the Immunotoxicity of the Pesticide 3,4-Dichloropropionanalide
The pesticide 3,4-dichloropropionanilide (propanil or, alternatively, DCPA) is a member of the acetanilide chemical family and is predominantly used for the control of weeds on commercial rice crops worldwide. This article was written to provide a brief review of the general toxicity of propanil followed by a detailed summary of the immunotoxicity studies that were performed to date in mammalian in vivo and in vitro models. Propanil affects the immune system at organ, cellular, and molecular levels. Studies demonstrated that it produces thymic atrophy and splenomegaly and decreases developing T- and B-cell populations in the thymus and bone marrow. Natural killer (NK) cells and macrophages are critical components of the innate immune system. NK cell cytotoxicity and the ability of macrophages to phagocytose, kill pathogenic bacteria, and produce inflammatory cytokines are suppressed by propanil. Propanil also affects the respiratory burst of macrophages, inhibiting reactive oxygen and nitrogen species production. Molecular mechanisms responsible for propanil's effects have begun to be elucidated and include alterations in nuclear factor (NF)-κB transcription factor activity and intracellular Ca2+ signaling. Propanil exposure alters a number of functions of mature T lymphocytes and B lymphocytes that impacts the adaptive immune response. T-cell cytotoxic activity and cytokine production are major T-cell functions inhibited by propanil. The humoral antibody response to model antigens and intact bacteria is differentially affected after propanil exposure. How these changes in innate and adaptive immune responses impact the host response to bacterial challenge or vaccination has begun to be examined.